Globus Medical, Inc.
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership68,659 shares
Latest Disclosed Value $ 5,915,660
Franklin Resources Inc reports 15.50% increase in ownership of GMED / Globus Medical, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 68,659 shares of Globus Medical, Inc. (MX:GMED) valued at $5,915,660 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 59,445 shares of Globus Medical, Inc.. This represents a change in shares of 15.50% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GLOBUS MED CL A 379577208 68,659 9,214 15.50 5,916 13.97 0.0002
2026-02-11 2025-12-31 13F GLOBUS MED CL A 379577208 59,445 54,197 1,032.72 5,190 1,630.00 0.0013
2025-11-13 2025-09-30 13F GLOBUS MED CL A 379577208 5,248 5,248 301 0.0001
2025-08-12 2025-06-30 13F GLOBUS MED CL A 379577208 0 -22,300 -100.00 0 -100.00
2025-05-13 2025-03-31 13F GLOBUS MED CL A 379577208 22,300 -103,524 -82.28 1,632 -84.32 0.0005
2025-02-12 2024-12-31 13F GLOBUS MED CL A 379577208 125,824 71,979 133.68 10,407 171.48 0.0029
2024-11-27 2024-09-30 13F/A-1 GLOBUS MED CL A 379577208 53,845 53,845 3,833 0.0011
2024-11-12 2024-09-30 13F GLOBUS MED CL A 379577208 53,845 53,845 3,833 0.0002
2023-02-10 2022-12-31 13F GLOBUS MED CL A 379577208 0 -4,284 -100.00 0 -100.00
2022-11-14 2022-09-30 13F GLOBUS MED CL A 379577208 4,284 4,284 255 0.0001
2022-08-11 2022-06-30 13F GLOBUS MED CL A 379577208 0 -12,961 -100.00 0 -100.00
2022-05-13 2022-03-31 13F GLOBUS MED CL A 379577208 12,961 1,447 12.57 956 15.04 0.0004
2022-02-11 2021-12-31 13F GLOBUS MED CL A 379577208 11,514 137 1.20 831 -4.70 0.0003
2021-11-12 2021-09-30 13F GLOBUS MED CL A 379577208 11,377 11,377 872 0.0003
2020-05-13 2020-03-31 13F GLOBUS MED CL A 379577208 0 -3,685 -100.00 0 -100.00
2020-03-11 2019-12-31 13F/A-1 GLOBUS MED CL A 379577208 3,685 3,685 217 0.0001
2020-02-12 2019-12-31 13F GLOBUS MED CL A 379577208 3,685 217
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.